SCHEMBL16377653

SCHEMBL16377653

COc1cc(/N=N/c2ccc([N+](=O)[O-])cc2)c(OC)cc1/N=N/c1ccc(N(C)CCCC(=O)NCCS)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP14 P50281 1/20 0.56
▸ MAPT P10636 7/20 0.40
▸ ALDH1A1 P00352 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CDC25C P30307 1/20 0.36
▸ GAA P10253 2/20 0.35
▸ PKM P14618 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ THRB P10828 1/20 0.35
▸ APEX1 P27695 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ POLB P06746 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17766830 1.00 MMP14 (0.56) MMP14MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL17780683 0.88 MAPT (0.41) MMP14MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL2002779 0.85 MMP14 (0.78) MMP14MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL31672216 0.85 MMP14 (0.78) MMP14MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL13401334 0.85 MMP14 (0.78) MMP14MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL24554531 0.83 MMP14 (0.55) MMP14MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL25712978 0.83 MMP14 (0.61) MMP14MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL19456492 0.80 MMP14 (0.56) MMP14MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL13881798 0.80 MMP14 (0.42) MMP14MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL16377647 0.79 MMP14 (0.64) MMP14MAPTALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10131626-B2 3-aryl propiolonitrile compounds for thiol labeling UNIVERSITE DE STRASBOURG (FR) 2018-11-20 — — US disclosed
US-20170210700-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-07-27 — — US disclosed
US-9663454-B2 3-aryl propiolonitrile compounds for thiol labeling UNIVERSITE DE STRASBOURG (FR) 2017-05-30 — — US disclosed
WO-2015001117-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING UNIVERSITE DE STRASBOURG (FR) 2015-01-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10131626-B2 3-aryl propiolonitrile compounds for thiol labeling PTMS, TST, PNN MMP14 4679/4885MAPT 885/4885ALDH1A1 30/4885
US-20170210700-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING PTMS, TST, PNN MMP14 4679/4885MAPT 885/4885ALDH1A1 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback